Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Herm Jan M Brinkman"'
Autor:
Joseph R Shaw, Tyler James, Jonathan Douxfils, Yesim Dargaud, Jerrold H Levy, Herm Jan M Brinkman, Risa Shorr, Deborah Siegal, Lana A Castellucci, Peter Gross, Roy Khalife, Christine Sperling, David Page, Dean Fergusson, Marc Carrier
Publikováno v:
PLoS ONE, Vol 18, Iss 11, p e0293632 (2023)
IntroductionHemostasis and bleeding are difficult to measure. Thrombin generation assays (TGAs) can measure both procoagulant and anticoagulant contributions to coagulation. TGAs might prove useful for the study of bleeding disorders. There has been
Externí odkaz:
https://doaj.org/article/2d470222b64f48ac860bd595f5bbe481
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 5, Pp n/a-n/a (2022)
Abstract Background Both andexanet alfa and four‐factor prothrombin complex concentrate (4F‐PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in emergency situations. Controversy exists whether 4F‐PCC is as eff
Externí odkaz:
https://doaj.org/article/583703f2c07d49769b9fd32973e174b0
Autor:
Herm Jan M. Brinkman, Frauke Swieringa, Marleen Zuurveld, Alicia Veninga, Sanne L. N. Brouns, Johan W. M. Heemskerk, Joost C. M. Meijers
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 3, Pp n/a-n/a (2022)
Abstract Background Prothrombin complex concentrate (PCC) is a human plasma‐derived mixture of partially purified vitamin K‐dependent coagulation factors (VKCF). Current therapeutic indication is treatment and perioperative prophylaxis of bleedin
Externí odkaz:
https://doaj.org/article/686b1ea5e4d14d848f33507bf2dc4b31
Autor:
Roisin Bavalia, Rahat Abdoellakhan, Herm Jan M. Brinkman, Marjolein P. A. Brekelmans, Eva N. Hamulyák, Marleen Zuurveld, Barbara A. Hutten, Peter E. Westerweel, Renske H. Olie, Hugo ten Cate, Marieke Kruip, Saskia Middeldorp, Karina Meijer, Michiel Coppens
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 4, Pp 569-581 (2020)
Abstract Background In the initial absence of specific reversal agents for factor Xa inhibitors (FXa‐Is), prothrombin complex concentrate (PCC) as a hemostatic agent has been recommended by guidelines. Since 2017, idarucizumab has been registered f
Externí odkaz:
https://doaj.org/article/c345245df8e24ff4a9568e4a78c0f1cb
Autor:
Josefin Ahnström, Björn Dahlbäck, Elisabetta Castoldi, Richard A. Marlar, Herm Jan M. Brinkman
Publikováno v:
Journal of Thrombosis and Haemostasis, 19(1), 281-286. Wiley
Hereditary deficiencies of protein S (PS) increase the risk of thrombosis. However, assessing the plasma levels of PS is complicated by its manifold physiological interactions, while the large inter-individual variability makes it problematic to esta
Autor:
Richard A. Marlar, Jana N. Gausman, Marian A. Rollins-Raval, Herm Jan M. Brinkman, Hiroko Tsuda
Publikováno v:
Journal of Thrombosis and Haemostasis. 19:68-74
Hereditary deficiencies of protein S (PS) increase the risk of venous thrombosis; however, assessing the plasma levels of PS can be difficult because of its complex physiological interactions in plasma, sample-related preanalytical variables, and num
Autor:
Herm Jan M. Brinkman, Saskia Middeldorp, Barbara A. Hutten, Marjolein P. A. Brekelmans, Michiel Coppens, Marieke J. H. A. Kruip, Eva N. Hamulyák, Rahat A. Abdoellakhan, Karina Meijer, Peter E. Westerweel, Hugo ten Cate, Renske H. Olie, Marleen Zuurveld, Roisin Bavalia
Publikováno v:
Research and practice in thrombosis and haemostasis, 4(4), 569-581. Wiley
Research and Practice in Thrombosis and Haemostasis, 4(4), 569-581. Wiley-Blackwell Publishing Ltd
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 4, Pp 569-581 (2020)
Research and practice in thrombosis and haemostasis, 4(4), 569-581. Wiley-Blackwell Publishing Ltd
Research and Practice in Thrombosis and Haemostasis, 4(4), 569-581. Wiley-Blackwell Publishing Ltd
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 4, Pp 569-581 (2020)
Research and practice in thrombosis and haemostasis, 4(4), 569-581. Wiley-Blackwell Publishing Ltd
Background In the initial absence of specific reversal agents for factor Xa inhibitors (FXa-Is), prothrombin complex concentrate (PCC) as a hemostatic agent has been recommended by guidelines. Since 2017, idarucizumab has been registered for dabigatr
Autor:
Marleen Zuurveld, Joost C. M. Meijers, Mikko Manninen, Herm Jan M. Brinkman, Riitta Lassila, Tuukka Helin
Publikováno v:
Transfusion. 58:3014-3026
BACKGROUND: Uncontrollable bleeding is the leading cause of death in traumatically injured patients. The extent to which direct factor Xa inhibitors interfere with the applied resuscitation measures is presently unknown. STUDY DESIGN AND METHODS: In
Publikováno v:
Thrombosis research, 170, 97-101. Elsevier Limited
Calibrated automated thrombography (CAT) is useful in monitoring the anticoagulant status of patients treated with direct oral anticoagulants (DOACs). This as well as other applications of the CAT are hampered by the wide inter-individual variation,
Autor:
Tuukka A, Helin, Marleen, Zuurveld, Mikko, Manninen, Joost C M, Meijers, Riitta, Lassila, Herm Jan M, Brinkman
Publikováno v:
Transfusion. 58(12):3014-3026
BACKGROUND: Uncontrollable bleeding is the leading cause of death in traumatically injured patients. The extent to which direct factor Xa inhibitors interfere with the applied resuscitation measures is presently unknown. STUDY DESIGN AND METHODS: In